• Wion
  • /World
  • /Gilead starts clinical trials of Remdesivir with US lawmakers curious about selling price

Gilead starts clinical trials of Remdesivir with US lawmakers curious about selling price

Gilead starts clinical trials of Remdesivir with US lawmakers curious about selling price

Gilead

Gilead is acompany that makes Remdesivir, another drug, that experts say holds promise against coronavirus.

In the US, Remdesivir is undergoing clinical trials. America's top health expert Dr. Anthony Fauci says it can block the virus.

That one statement made heads turn. Not just doctors, even investors began betting on Remdesivir.Needless to say, this was a shot in the arm for Gilead. Its shares gained by six per cent after the endorsement from Dr. Fauci.

Add WION as a Preferred Source

Five days ago, the federal drug administration in the United States has given its approval to Remdesivir. USPresident Donald Trump made the announcement himself, with Gilead CEOstanding right next to him.

But, will Remdesivir be the cure that no one can afford? Gilead is under watch, not because it has one of the most promising coronavirus treatments.

US Lawmakers want to know how much Gilead will charge for Remdesivirbecause Gilead has a reputation for charging sky high prices.

In 2015, the company had charged 84 thousand dollars for a Hepatitis C drug. It didn't happen by accident, this was by design.

The Senate finance committee invested Gilead's pricing. This is a standing committee of lawmakers in the USSenate.

Gilead knew that affordable pricing would allow more patients to be treated. But, it still pursued profits. The company wanted to maximize its profits. What it didn't anticipate was the angry backlash; Gilead had to suffer through a spate of bad publicity.